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Abstract  17 
Background:  Equine influenza virus is a highly contagious respiratory pathogen 18 
that causes pyrexia, anorexia, lethargy and coughing in immunologically naïve 19 
horses. Vaccines against equine influenza are available and vaccination is 20 
mandatory for horses that participate in affiliated competitions, but this group forms a 21 
small proportion of the total horse population. The aims of this study were to: i) 22 
identify the equine influenza vaccination rate as reported in 2016 by horse owners in 23 
the United Kingdom (UK); ii) examine the demographics of owners and horses which 24 
were associated with significantly lower influenza vaccination rates and iii) explore 25 
factors that influence horse owners’ decisions around influenza vaccine uptake.  26 
Results: Responses from 4,837 UK horse owners who were responsible for 10,501 27 
horses were analysed. An overall equine influenza vaccination rate of 80% 28 
(8385/10501) was reported. Several owner demographic characteristics were 29 
associated with significantly lower (p<0.05) reported equine influenza vaccination 30 
rates including: some geographical locations, increasing horse owner age, annual 31 
household income of less that £15,000 and owning more than one horse. Horse-32 
related features which were associated with significantly lower reported equine 33 
influenza vaccination rates included age ranges of <4 years and > 20 years, use as a 34 
companion or breeding animal or leaving their home premises either never or at 35 
most once a year. The most common reasons cited for failing to vaccinate horses 36 
was no competition activity, lack of exposure to influenza and expense of vaccines. 37 
In contrast, the most common underlying reasons given by horse owners who 38 
vaccinated their horse were protection of the individual horse against disease, 39 





less previous experience of an influenza outbreak or adverse reaction to vaccination 41 
compared with owners of unvaccinated horses. 42 
Conclusions:  This study documented a high rate of equine influenza vaccination as 43 
reported by owners in a substantial number of horses in the UK, but this does not 44 
reflect the level of protection. Sub-populations of horses which were less likely to be 45 
vaccinated and the factors that influence each owner’s decision around vaccination 46 
of their horses against equine influenza were identified, but may alter following the 47 
2019 European influenza outbreak. This information may nevertheless help 48 
veterinary surgeons identify “at-risk” patients and communicate more personalised 49 
advice to their horse-owning clients. It may also influence educational campaigns 50 
about equine influenza directed to horse owners, which aim to improve uptake of 51 
vaccination against this pathogen.   52 
 53 
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1. Introduction   60 
Equine influenza A virus causes a contagious respiratory tract infection (Paillot, 61 
2014; Sack, 2019), with 100% morbidity in populations of naïve animals that are 62 
exposed. Clinical signs in naïve horses include pyrexia, lethargy and anorexia, a 63 
harsh dry cough and serous nasal discharge (Wood et al., 2006). In primed horses, 64 
clinical signs are more mild and of shorter duration. In the majority of horses, the 65 
mortality rate arising from equine influenza is low, but secondary bacterial infection, 66 
which presents as a mucopurulent nasal discharge and an extended fever, can 67 
increase mortality in a small number of cases (Wood et al., 2006).  The majority of 68 
equine influenza virus transmission occurs through close contact between infectious 69 
and naïve individuals, but this virus is highly infectious and can also be spread by 70 
transport of infected animals, contaminated personnel and equipment or in a wind-71 
borne aerosol over 1-2 km, as reported in South Africa and Australia (Guthrie et al., 72 
1999; Davis et al., 2009).  73 
 74 
In 2007, a notable outbreak of equine influenza occurred in unvaccinated horses in 75 
Australia, which was previously free of the disease (Callinan, 2008; Webster, 2011). 76 
The cost of controlling this equine influenza outbreak amongst the naïve Australian 77 
horse population and regaining the country’s disease-free status was estimated at 78 
approximately 270 million Australian dollars (Callinan, 2008), demonstrating the 79 
potentially large economic impact of such an outbreak. Other recent notable equine 80 
influenza outbreaks have occurred in unvaccinated horses and donkeys in India and 81 
Nigeria (Virmani et al., 2010; World Organisation for Animal Health (OIE), 2019a), 82 





unvaccinated horses in the UK, Ireland and France in 2019 (Newton, 2019; Animal 84 
Health Trust, 2020).  85 
 86 
Inactivated whole virus vaccines have been used against equine influenza since the 87 
1960s. A range of vaccines, including subunit and recombinant virus products is 88 
currently available (Paillot, 2014; Daly and Murcia, 2018). For complete protection, 89 
these vaccines rely primarily on generating cell-mediated immunity (Hannant and 90 
Mumford, 1989; Paillot et al., 2006b; Paillot et al., 2007) and a strong, but often 91 
short-lived, antibody immune response to protect against exposure to homologous 92 
virus (Paillot et al., 2006a). Correlates of protection for cell mediated immunity 93 
remain to be identified. However a correlation between existing antibody levels, as 94 
measured by single radial haemolysis (SRH), and protection of horses against 95 
infection with a homologous strain of influenza virus has been established. Thus 96 
clinical (e.g. absence of fever, cough) or virological (significant reduction in 97 
nasopharyngeal virus shedding) protection against homologous strains requires 98 
>85mm2 or >154mm2 SRH antibody areas respectively (Mumford and Wood, 99 
1992). 100 
 101 
In April 2019, the recommendations of the World Organisation for Animal Health 102 
(OIE) expert advisory panel on equine influenza advised that vaccines should 103 
contain representative strains of both the H3N8 Florida sub-lineages, namely clade 1 104 
( e.g. A/equine/South Africa/04/2003-like or A/equine/Ohio/2003-like) and clade 2 105 
(e.g. A/equine/Richmond/1/2007-like) (World Organisation for Animal Health (OIE), 106 
2019b). These recommendations, which are reviewed annually, have remained the 107 





Florida clades 1 and 2 circulate currently (Animal Health Trust, 2020). Here, three 109 
vaccines are available against equine influenza, only one of which complies with the 110 
current OIE recommendations to include both H3N8 Florida clade 1 and clade 2 111 
(ProteqFlu, Boehringer Ingelheim; A/equine/Ohio/2003 and 112 
A/equine/Richmond/2007;(Animal Health Trust, 2020)). The other two vaccines 113 
contain European and American (Kentucky) strains (Equip F, Zoetis; 114 
A/equine/Borlange/1991; A/equine/Kentucky/1998) or European and Florida clade 1 115 
strains (Equilis Prequenza, MSD Animal Health; A/equine/Newmarket/2/1993; 116 
A/equine/South Africa/2003) respectively (Durham, 2019). However despite these 117 
apparent shortcomings, shortly after a third vaccination of yearling horses, all three 118 
vaccines stimulated single radial haemolysis antibody responses against Florida 119 
clade 2 strain (A/equine/Richmond/1/2007) which are associated with clinical and 120 
virological protective immunity (Dilai et al., 2018) and Equip F shows cross protection 121 
against virulent challenge for representative strains of Florida clades 1 and 2 (Paillot 122 
et al., 2008; Bryant et al., 2010; Paillot, 2015) . Nevertheless, if influenza infection 123 
occurs in vaccinated animals, clinical signs are more mild and of shorter duration. 124 
However, in addition to providing complete or partial protection of individuals against 125 
infection, the aim of vaccination is to reduce the amount of virus shed from the 126 
nasopharynx and thus limit the spread of infection to other equids. In the UK, 127 
influenza vaccination (at least annual) is compulsory for horses competing under the 128 
regulations of affiliated organisations such as the British Horseracing Authority 129 
(Thoroughbred horseracing), British Show Jumping, British Eventing and Federation 130 
Equestre Internationale, but there is no mandatory vaccination of non-competitive, 131 





 Despite the requirements for compulsory vaccination in some disciplines, there have 133 
been periodic epidemics of equine influenza, particularly in unvaccinated animals in 134 
the UK in 2003 (Newton et al., 2006)  and more recently in 2019 (Newton, 2019; 135 
Animal Health Trust, 2020). In the latter, Thoroughbred horseracing was cancelled 136 
for six days, resulting in a substantial interruption to racehorse training and racing 137 
schedules and financial losses to the economy. Non-Thoroughbred horses and 138 
equestrian events were also affected, which required dissemination of consistent 139 
advice to veterinary surgeons and horse-owners, particularly in relation to booster 140 
vaccination (Newton, 2019) (https://www.aht.org.uk/disease-surveillance/equiflunet; 141 
https://www.britishhorseracing.com/regulation/equine-influenza-update/). 142 
 143 
Mathematical models show a dramatic reduction of influenza outbreaks among 144 
groups of vaccinated horses (reviewed in Daly et al. (2013)). However, the efficacy 145 
of influenza vaccines depends on a close match between the virus strain(s) 146 
incorporated in the vaccine and the strain(s) circulating in the field. Where there is a 147 
mismatch between the vaccine strain and circulating virus, much higher levels of 148 
antibody are required to prevent an individual from becoming infected. From 149 
mathematical models, it is estimated that vaccine coverage of 40% of the population 150 
is sufficient to prevent outbreaks involving homologous strains, i.e. provide “herd 151 
immunity” (Park et al., 2009). However, as the virus evolves over time, the 152 
effectiveness of vaccines containing older strains is reduced, increasing the risk of 153 
outbreaks occurring (Park et al., 2004). Models have illustrated that, following an 154 
accumulation of 4 or 5 amino acid changes in key regions of the virus, at least 70% 155 
of horses must be vaccinated to provide herd immunity and with 6 changes, this 156 






A limited number of studies into the influenza vaccination status of leisure or pet 159 
horses in the UK have been conducted. These have described the influenza 160 
vaccination rate as reported by horse-owners ranging between 79% and 91% 161 
(Hotchkiss et al., 2007; Boden et al., 2013; Ireland et al., 2013). In contrast, based 162 
on sales of influenza virus vaccines in the UK, which can only be prescribed and 163 
administered by veterinary surgeons, the estimated annual vaccination rate is <50% 164 
(MSD, 2017). Recent data estimates that there are between 847,000 and 1,350,000 165 
horses in the UK (Boden et al., 2012; British Equestrian Trade Association (BETA), 166 
2019). A total of 4,098 horses (98.3%), asses (0.2%) and mules (1.5%) were 167 
imported (Food and Agricultural Organization of the United Nations (FAO), 2017), 168 
but it is likely that the majority of imported horses were high value bloodstock or 169 
racing Thoroughbreds or sports horses. In one national survey, 98% (3419/3482) of 170 
respondents reported that they rode (Boden et al., 2013), with 1.8 million riding at 171 
least once a month in the past 12 months (British Equestrian Trade Association 172 
(BETA), 2019). Another report stated that around 60% of riders compete in non-173 
affiliated events (British Equestrian Trade Association (BETA), 2015). These data 174 
indicate the size and mobility of the leisure horse population within the UK, but their 175 
influenza vaccination status and factors which influence vaccine decisions by owners 176 
are unknown. The aims of this study were first to identify the equine influenza 177 
vaccination rate as reported in 2016 by horse owners in the United Kingdom (UK), 178 
second, to examine the demographics of owners and horses which were associated 179 
with significantly lower reported influenza vaccination rates and third, to explore 180 






2. Materials and Methods  183 
2.1 Survey Design 184 
This study was approved by the School of Veterinary Medicine and Science’s 185 
Research and Ethics committee (University of Nottingham) and participants gave 186 
informed consent. A modified tailored design was used to create a mixed method 187 
directional survey in English via esurveycreator®, applying the authors’ expertise in 188 
equine infectious respiratory viral disease (JMD and JHK). A pilot survey was 189 
completed by 15 individual volunteers who were horse owners, including veterinary 190 
students, riders and horse trainers and thus formed a convenience sample: two 191 
questions were removed and four shortened to produce the final survey 192 
(Supplementary Figure 1) in which each participant was asked a total of 29 193 
questions, of which 26 were compulsory to progress. The directional nature allowed 194 
appropriate yet consistent phrasing and collection of relevant data, depending on 195 
whether participants vaccinated their horse or not. Only one completion was 196 
permitted per participant and the survey took approximately 10 minutes, although 197 
participants could exit the survey and resume later. To determine any variation in 198 
vaccination status of horses owned by the same person, the survey allowed 199 
collection of data for up to 5 horses per participant, all of which were anonymised. 200 
Closed questions were used to collect information on the geographical location, age, 201 
gender and income of participants, the age and reported vaccination status of their 202 
horses, as well as the purpose for which they were kept and frequency of leaving 203 
their home premises for any reason, including a hack. The assumption was made 204 
that horse(s) were located in the same geographical region as their owners. In some 205 
questions, participants were asked to indicate how much they agreed with several 206 





strongly agree (7), with an eighth option for ‘does not apply’. To collect information 208 
on how influential different factors were on horse owners’ decisions to vaccinate 209 
against equine influenza, a separate set of statements was presented to participants 210 
who reported vaccinating either all, some or none of their horses. Owners used a 211 
visual analogue scale ranging from 0 (no influence) to 100 (significant influence) to 212 
assess nine pre-determined categories. These categories were horse welfare, 213 
competition requirements, financial situation, advice from their vet, scientific reports, 214 
national herd protection, online forums and social media, opinions of friends or pony 215 
club recommendations. There was one open question to record any additional 216 
factors that affected participants’ decisions around vaccination. The survey was 217 
released online on the 5th July 2016 and closed on the 19th October 2016. 218 
 219 
2.2 Survey Distribution  220 
The online survey titled “Calling all horse owners”, was distributed and publicised 221 
through a number of media outlets, including a University of Nottingham press 222 
release, regional TV news, a national equestrian magazine and equestrian 223 
associations via their members’ mailing lists. The survey was also heavily promoted 224 
at regular intervals on social media platforms. A poster with a QR code and web 225 
address for the survey was displayed on notice boards at local equine retail stores, 226 
selected competitions and livery stables (Supplementary Figure 2). Participants who 227 
completed the survey were entered into a prize draw to win £150 worth of vouchers. 228 
 229 
2.3 Data and thematic analysis  230 
Data were downloaded into Microsoft Excel 2010 (Microsoft®, Redmond, USA) and 231 





International Ltd., Rothampsted, UK). Odds ratios (ORs) with 95% confidence 233 
intervals (CI) were generated from ordinal and multinomial logistic regression 234 
analysis to examine the strength of the relationship between categorical variables 235 
and reported vaccination status and represent the strength of any predictive factors. 236 
An OR not equal to 1, with confidence intervals which did not overlap the confidence 237 
intervals of the null value (OR=1) was considered significant (p<0.05). OR reference 238 
categories were selected as the median by GenStat or based on the most logical 239 
selection. Owner ages were grouped in an attempt to reflect young adults, adults, 240 
middle aged adults and those of elderly status. Owner reference categories were 241 
selected as 18-25 years, because this age range is most likely to be competing and 242 
a salary range of £15,000-£34,999, because it included the national average income 243 
of £28,600 in 2016 (Office for National Statistics, 2017). Horse ages were grouped 244 
into six categories at 5 year intervals for convenience and to reflect the stage of their 245 
training / ridden career e.g. horses 0-4 years were likely to be un-ridden or in the 246 
early stages of ridden training, whereas horses >20 years tend to compete less. 247 
Thus horse related reference categories were selected as 5-9 years (the age when 248 
horses commonly start to compete). Other reference categories were chosen 249 
arbitrarily. Chi-squared tests with Yates’ correction were used to assess the 250 
statistical independence between use of horse and reported vaccination status. The 251 
statistical significance of the variations between median values of those respondents 252 
who reported vaccinating their horses against equine influenza virus and those who 253 
did not were analysed using Mann-Whitney U tests. For all statistical tests, p<0.05 254 
was considered significant. All data presented relate to vaccination against equine 255 
influenza virus as reported by horse owners and for most analyses, each horse was 256 





person. The exceptions were the analysis of the influence of previous experience of 258 
a horse owner in relation to an influenza outbreak, adverse reaction and reasons 259 
which influenced horse owners around influenza vaccination. In these instances, the 260 
vaccination status of all horses owned by the same person was identified as either 261 
all vaccinated or all non-vaccinated or a mix of vaccinated and non-vaccinated 262 
(“both”). 263 
 264 
Thematic analysis was used to interpret the qualitative data arising from one open 265 
question, which aimed to capture other factors which influenced horse owners’ 266 
decisions on equine influenza vaccination. The response(s) by each horse owner 267 
was assigned to one or more codes which were in turn amalgamated into themes. 268 
The topic of each theme was either one which arose from quantitative data analysis 269 
or novel, as appropriate.  270 
 271 
3. Results  272 
3.1 Survey inclusion criteria 273 
The final survey was started by 6,547 participants. Participants who did not complete 274 
the survey (1,242), those who lived outside the UK (468) and those who owned only 275 
donkeys were excluded. Therefore final data for analysis comprised a maximum of 276 
4,837 owners of a total of 10,501 horses. Throughout the results, the number of 277 
responses to individual questions are detailed. Full details of the numbers, 278 
percentages and statistical analysis including odds ratios with 95% confidence 279 
intervals, z statistics and p values are shown in Supplementary Tables 1 and 2. 280 
 281 





The majority of participants were female (98.5%, 4765/4837) and were aged 283 
between 41–60 years (43%, 2061/4837). The annual household income ‘£15,000 to 284 
£34,999’ was most common, with 30% (1469/4837) of participants in this category 285 
(Table 1). Most horse owners owned one horse (40%; 1955/4837). All UK regions 286 
were represented, ranging from 0.8% (41/4837) respondents in Greater London to 287 
19% (926/ 4837) in the South East of England and 14% in both the South West 288 
(668/4837) and East of England (675/4837). Respondents from all other areas 289 
represented <10% of the total number of participants. 290 
 291 
3.3 Equine influenza virus vaccination rate and regional distribution 292 
The overall reported equine influenza virus vaccination rate was 80% (8385/10501). 293 
The highest reported influenza vaccination rate, 85% (1656/1954), was in horses 294 
owned by participants who lived in the South East (Figure 1a). Odds ratio analysis 295 
using East Midlands as a reference category (79%; 786/989), showed that horse 296 
owners in the South East of England were more likely to vaccinate (85%, 1656/1954; 297 
p=0.0003) whereas those in Wales (63%, 334/528; p<0.0001), the South West 298 
(73%,1056/1443;p=0.0004), West Midlands (73%, 624/849; p=0.0026) and Scotland 299 
(74%, 679/916; p=0.0057) were significantly less likely to vaccinate (Figure 1a; 300 
Supplementary Table 1, Section 1a). 301 
 302 
3.4 Horse owner-related factors associated with reported influenza vaccination  303 
3.4.1 Gender and age  304 
There was no significant difference between the gender of an owner and the 305 
reported equine influenza vaccination status of their horse(s) (p=0.129; 306 





years (83%, 1588/1911), owners in all age groups >26 years were significantly less 308 
likely to report vaccinating their horse(s) against equine influenza virus (26-40 years, 309 
79%; 2534/3207, p=0.002; 41-60 years, 78%, 3716/4793, p<0.001; >60 years, 70%, 310 
415/590, p<0.001; Figure 1b; Supplementary Table 1, Section 1c).  311 
 312 
3.4.2 Income  313 
The reference category of ‘£15,000-£34,999’ was chosen as representative of the 314 
average UK salary of £28,600 in 2016 (Office for National Statistics, 2017). 315 
Compared with the reference category (78%, 2402/3063), horses owned by 316 
participants with an annual household income of ‘Less than £15,000’ had the lowest 317 
reported equine influenza vaccination rates (69%, 806/1162, p<0.0001). Participants 318 
earning ‘£55,000-£74,999’ and ‘£95,000 or more’ had significantly higher reported 319 
equine influenza vaccination rates (83%, 901/1086; p=0.0014; 86%, 526/621, 320 
p=0.0004 respectively; Figure 1c; Supplementary Table 1, Section 1d) compared 321 
with the reference category.  322 
 323 
3.4.3 Number of horses owned 324 
Reported equine influenza vaccination rates were highest when only one horse was 325 
owned (88%, 1721/1957; Figure 1d; Supplementary Table 1, Section 1e). Odds ratio 326 
analysis using one horse as the reference category showed that reported vaccination 327 
rates were significantly lower if more than one horse was owned (2 horses, 81%, 328 
2241/2765, p<0.0001; 3 horses 79%, 1651/2090, p<0.0001; 4 horses, 76%, 329 







3.5 Horse-related factors associated with reported influenza vaccination  333 
3.5.1 Age 334 
Horses in the age category of 10-14 years had the highest reported equine influenza 335 
vaccination rates (84%, 2062/2456) while the reported lowest vaccination rates were 336 
seen in horse age category 25->36 years (55%, 316/579; Figure 2a; Supplementary 337 
Table 1, Section 2a). The median age of horses reportedly vaccinated was 11 years, 338 
whereas the median age of reported non-vaccinated horses was 15 years (p<0.001). 339 
The reference category of 5-9 year old horses had a reported vaccination of 83% 340 
(2728/3275). Using this reference value, horses in each of the age categories 0-4, 341 
20-24 and 25->36 years were significantly less likely to be reported as vaccinated 342 
(72%, 809/1120, p<0.0001; 69%, 813/1172, p<0.0001; 55%, 316/579, p<0.0001 343 
respectively).  344 
 345 
3.5.2 Use 346 
The highest reported equine influenza vaccination rates were recorded in horses 347 
used for competitions, whether affiliated and unaffiliated (88%, 918/1047; 86%, 348 
2047/2389 respectively; Figure 2b; Supplementary Table 1, Section 2b). The lowest 349 
reported equine influenza vaccination rates were noted in horses used solely for 350 
breeding or companionship (64%, 141/220 and 67%, 1552/2293, respectively). The 351 
reference category of hacking had 79% (2603/3289) reported vaccinated. Odds ratio 352 
analysis showed the reported influenza vaccination rates were significantly higher for 353 
horses in affiliated and unaffiliated competitions but lower in horses used solely for 354 
breeding or as companions (affiliated competitions p<0.0001; non-affiliated 355 





horses used for leisure riding approached significance (leisure riding p=0.052; Figure 357 
2b). 358 
 359 
3.5.3 Frequency of leaving yard 360 
Horses that left the premises at which they were stabled on a daily basis had the 361 
highest reported equine influenza vaccination rates (83%, 127/153). The reference 362 
category of leaving once a month had 75% (298/396) reported vaccination rates; in 363 
comparison with this, horses that left their home premises less than once a year 364 
(54%, 63/116, p<0.0001), once a year (60%, 37/62, p=0.011) or never (30%, 96/324, 365 
p<0.0001) had significantly lower reported vaccination rates (Figure 2c; 366 
Supplementary Table 1, Section 2c).  Horses which left daily (83%, 127/153, p=0.05) 367 
or 2-6 times a week (80%, 1158/1444, p=0.032) or 2-3 times a month (82%, 368 
719/879, p=0.007) were significantly more likely to be reported as vaccinated against 369 
equine influenza compared with the reference category.  370 
 371 
3.6 Owner-related factors associated with reported equine influenza vaccination 372 
3.6.1 Underlying reasons 373 
Owners were asked to indicate on a visual analogue Likert scale how influential 374 
various factors were on their decision to vaccinate their horse(s) against equine 375 
influenza. The eight options ranged from “Strongly disagree” (1) to “Strongly agree” 376 
(8) with “neutral” (4) and “does not apply” (0) available. The majority of horse owners 377 
who reported vaccinating their horse against equine influenza agreed slightly, 378 
moderately or strongly with the statement “I vaccinate to protect my horse from 379 
equine influenza” (86%, 2846/3624), followed by national herd protection (43%, 380 





Section 3a). In contrast, of horse owners who reported not vaccinating their horse 382 
against equine influenza, the majority selected “My horse does not compete in 383 
affiliated competitions” (65%, 793/1215), followed by horse not exposed (42%, 384 
512/1215) and expense (36%, 435/1215; Figure 3b; Supplementary Table 1, Section 385 
3b). Responses relating to the most popular reason for reported vaccination or non-386 
vaccination in each category were polarised towards “strongly agree”.  387 
 388 
3.6.2 Impact of previous experience of equine influenza outbreak or adverse vaccine 389 
reaction 390 
For this analysis, participants were split into three groups based on whether they 391 
reported vaccinating: (i) all of their horses (‘vaccinate’ = 75%, 3623/4837); (ii) some 392 
but not all of their horses (‘both’ = 13%, 629/4837); (iii) none of their horses (‘non-393 
vaccinate’ = 13%, 585/4837). A small number of participants had experienced an 394 
equine influenza outbreak as diagnosed by a vet (5%, 242/4837; Supplementary 395 
Table 1, Section 3c) or had observed a self-assessed “adverse reaction” to equine 396 
influenza vaccination (19%, 933/4837; Supplementary Table 1, Section 3d). 397 
Compared with the ‘non-vaccinated’ reference group, owners in the ‘vaccinate’ group 398 
were significantly less likely to have had any experience of an equine influenza 399 
outbreak (4%, 152/3623; p<0.0001; Figure 4a) or to have observed a self-assessed 400 
“adverse reaction” to equine influenza vaccination (16%, 598/3623; p<0.001; Figure 401 
4b).  402 
 403 
3.6.3 Importance of underlying reasons 404 
The influence of nine pre-determined factors on horse owners’ decisions to vaccinate 405 





(no influence) to 100 (significant influence). These categories were horse welfare, 407 
competition requirements, financial situation, advice from their vet, scientific reports, 408 
national herd protection, online forums and social media, opinions of friends or pony 409 
club recommendations. Data were analysed according to the number of horses up to 410 
a maximum of five owned by one individual which were reported as ‘vaccinated’ by 411 
their owners, ranging from all vaccinated (5/5) to none vaccinated (0/5). In all groups, 412 
horse welfare was the most influential factor (median scores of 96, 80-95 and 76 out 413 
of 100 for the ‘vaccinate’ n=3623, ‘both’ n=629 and ‘non-vaccinate’ n=585’ groups 414 
respectively; Supplementary Table 1, Section 3e). For horse owners who reported 415 
vaccinating all five or at least two of their five animals, competition requirements, 416 
advice from their vet and scientific reports were most influential and had median 417 
scores that were significantly different from horse owners in the “non-vaccinate” 418 
group (p<0.001). Protection of the national herd gained influence with increasing 419 
numbers of horses reported vaccinated. In contrast, horse owners who reported 420 
vaccinating 1-3 of their five reported horses indicated that their financial position was 421 
more influential (range of median scores 50-58) than owners who vaccinated all five 422 
horses (median score 10) or none (median score 27). See Supplementary Table 1, 423 
Section 3e for interquartile ranges. 424 
 425 
3.7 Thematic analysis 426 
A total of 508 horse owners answered the open question “Please state any other 427 
factors that affect your decision on equine influenza vaccination” and analysis 428 
revealed 15 over-arching themes (Supplementary Table 2). Responses were also 429 
categorised as positive, mixed or negative attitudes towards influenza vaccination 430 





responses which were associated with a negative attitude towards vaccination 432 
included adverse vaccine reactions and minimal exposure to new horses. Factors 433 
cited by horse owners that had a positive attitude to influenza vaccination included 434 
insurance requirements and a sense of responsibility, although numbers of 435 
responses were small. Mixed attitudes to vaccination arose following advice from 436 
their vet or a local influenza outbreak.  437 
 438 
4. Discussion  439 
 440 
In this study, an overall reported equine influenza vaccination rate of 80% among 441 
10,501 horses was obtained from an online survey of horse owners in the United 442 
Kingdom during 2016, but this does not reflect the level of protection. This rate is 443 
comparable to the 79% (n=873) and 82% (n=797) rates previously found in mainland 444 
Britain (Hotchkiss et al., 2007; Ireland et al., 2013), but lower than others (91%, 445 
n=4601; (Boden et al., 2013). These consistently high overall equine influenza 446 
vaccination rates reported by respondents are at odds with the estimated number of 447 
530,000 vaccine doses sold by pharmaceutical companies in 2013, which equates to 448 
an estimated 53% vaccination rate (MSD, 2017). This suggests that a significant 449 
number of horses are not vaccinated annually which, until the 2019 influenza 450 
outbreak in the UK was the minimum interval recommended by vaccine 451 
manufacturers and various equine authorities. Several potential explanations for this 452 
discrepancy may be proposed. First, the high reported vaccination rate may be self-453 
selection bias whereby more horse-owners who vaccinated their horses participated. 454 
This is a recognised failing of an electronic survey approach (Sax et al., 2003; 455 





easily; the number of individual UK households with internet access has increased 457 
dramatically in recent years to 89% in 2016 (Office for National Statistics, 2016). 458 
Second, the survey’s publicity title, “Calling all horse owners” attempted to minimise 459 
sampling bias by avoiding the use of the word “vaccination”. Nevertheless it is 460 
possible that horse-owners who are actively engaged with their horses’ health were 461 
more likely to complete the survey. One qualitative study on attitudes to vaccination 462 
revealed that veterinary surgeons divided farmers into three groups, namely 463 
proactive, receptive to advice or disengaged (Richens et al., 2016); similar groups 464 
are likely to exist amongst horse owners. Third, the survey relied on recall by 465 
owners, who were not questioned specifically about the product administered or the 466 
frequency and time since last vaccination as this was deemed too unreliable; the 467 
question simply asked whether their horse had been vaccinated against equine 468 
influenza at some point in their memory. Ireland et al. (2013) reported that 4% of 469 
horses vaccinated against equine influenza received their last vaccination more than 470 
one year previously, thereby failing to meet manufacturer’s recommendations of at 471 
least annual vaccination in most horses or even bi-annual vaccination in high-risk 472 
populations. Others reported that 6% of the horses received vaccinations once every 473 
2 years (Mellor et al., 2001). Accessing veterinary records would have improved the 474 
quality of the data, but was too difficult logistically with the numbers of respondents 475 
and horses.  476 
 477 
The study had several strengths, for example, horse owners could record the 478 
vaccination status of up to five horses, which captured differences in reported 479 
vaccination status within horses owned by the same person. The directional nature 480 





vaccinating their horse or not. In addition, completion of the questions relating to 482 
vaccination was compulsory, largely because Boden et al. (2013) found that 20% of 483 
participants skipped the vaccination question in their survey, leading to the possibility 484 
that non-response bias led to an under-representation of non-vaccinated horses. A 485 
total of 81% of participants completed the current survey, likely encouraged by the 486 
use of a prize draw, regular publicity on social media and the ability to resume at a 487 
later date (Edwards et al., 2002; Boden et al., 2013). The completion rate decreased 488 
as the survey progressed, indicating that length may have discouraged some 489 
participants to complete and emphasising the need to avoid over-long surveys. The 490 
assumption that horse(s) are located in the same region as their owners was based 491 
on the finding by Boden (Boden et al., 2013) who reported that just over 90% of 492 
respondents to their survey kept their horses within 10 miles of their own home. In 493 
the current survey, Greater London was the least represented region by 494 
respondents, corresponding with the low density of horses reported in this area, 495 
whereas the high number of participants in areas such as the South East and the 496 
South West corresponded with the high density of horses in these regions (Boden et 497 
al., 2012).  498 
 499 
After completion of this survey, there was a widespread outbreak of equine influenza 500 
(American lineage, Florida clade 1 sub-lineage) amongst vaccinated and non-501 
vaccinated horses throughout the United Kingdom, Ireland and France in 2019, 502 
which led to the suspension of Thoroughbred horse racing in the UK for 6 days 503 
(https://www.aht.org.uk/disease-surveillance/equiflunet). Prior to this outbreak and 504 
after the previous widespread outbreak in 2003, one mathematical model predicted 505 





involving a smaller number of horses would be the trend (reviewed in (Daly et al., 507 
2013)). Up until 2013, the pattern of influenza outbreaks supported the model, but 508 
despite the high rate of equine influenza vaccination reported by horse-owners in the 509 
current and other studies, this was insufficient to prevent the substantial 2019 510 
incursion.  The size of the 2019 outbreak suggests that vaccination levels were 511 
insufficient to afford protection of the national herd. One potential explanation is that 512 
the true annual vaccination rate is lower than reported by horse owners and closer to 513 
that reported by pharmaceutical companies. In addition, a mismatch between the 514 
2019 influenza virus strain and the strains included in current vaccines may mean 515 
that a higher rate of vaccination is required to achieve herd immunity. The 516 
substantial size and well-publicised impacts of the 2019 influenza outbreak may 517 
assist in improving the actual uptake of vaccines against this virus by horse owners. 518 
 519 
In order to ensure a population is protected against an equine influenza outbreak 520 
with a homologous strain, at least 70% of horses must be vaccinated annually 521 
(Baker, 1986) and this rises to 95% if at least 6 amino acid HA substitutions arise 522 
(Park et al., 2009). Notably vaccination rates among some groups of horses reported 523 
here were significantly lower. This is concerning because in a population which is 524 
partially immune to influenza, the index case that triggers an outbreak is usually a 525 
seronegative horse (ie non-vaccinated or vaccinated >6 months previously) (Wood, 526 
1991). Several factors appeared to influence the reported equine influenza 527 
vaccination rate, including owner’s age >26 years old. It may be that older 528 
participants are less likely to compete in affiliated competition, removing any 529 
compulsory requirement for influenza vaccination of their horses. In contrast, a 530 





years were more likely to say their pets had received booster vaccinations (PDSA, 532 
2019). There was a significant association between annual household income and 533 
equine influenza vaccination rates, with participants on annual household incomes 534 
lower than the national average salary less likely to vaccinate their horse(s) against 535 
equine influenza. Vaccine cost was also important in Australian horse-owners who 536 
failed to vaccinate their horses against Hendra virus (Goyen et al., 2017). Owners 537 
located in the municipality of Wales reported the lowest rate of influenza vaccination 538 
but it is likely that confounding factors, in particular the use of horse, contribute to the 539 
regional trends observed. For example, Wales has very few affiliated eventing 540 
competitions for which vaccination is compulsory. Nevertheless a lower booster 541 
vaccination of pets (dogs, cats and rabbits) has been reported in Wales elsewhere 542 
(PDSA, 2019) so animals in this municipality may be more vulnerable to infectious 543 
disease. 544 
 545 
The reported equine influenza vaccination rate was inversely proportional to the 546 
number of horses owned. Thus 88% of owners reported that ‘horse 1’ was 547 
vaccinated, but this fell to 69% for ‘horse 5’, a pattern also observed by Koskinen 548 
(2014a) in Finland. This suggests that survey participants are more likely to record 549 
vaccinated horses first and before unvaccinated horses, which may have influenced 550 
data in previous studies that only analysed the first horse per participant (Hotchkiss 551 
et al., 2007; Boden et al., 2013; Koskinen, 2014a). In addition, Boden et al. (2013) 552 
assumed that all horses owned by a participant had the same equine influenza 553 
vaccination status. However, the current survey revealed that 13% of participants 554 
vaccinated some, but not all the horse(s) they owned. If all horses owned by one 555 





88% would have been found instead of 80%, illustrating the effect such an approach 557 
can have. It may also be speculated that as the number of horses owned and age of 558 
owners increase, their use may become more diverse (e.g. athletes, companionship, 559 
retired or bloodstock), for which equine influenza vaccination may be perceived as 560 
unnecessary.  561 
 562 
Significant differences were detected between age groups of horses and their 563 
reported equine influenza vaccination status. The highest reported vaccination rates 564 
were seen in horse age categories spanning 5 to 14 years. The eldest horses 565 
(category > 20 years), and the youngest horses (category <4 years) were less likely 566 
to be vaccinated against equine influenza, with an even lower figure (63%) of horses 567 
<1 year old reportedly vaccinated, although this is likely to include foals which were 568 
too young to be vaccinated. Koskinen (2014a) similarly found that participants gave 569 
‘too old’ and ‘too young’ as reasons for non-vaccination. The use or activity level of a 570 
horse is likely to be a confounding factor, with both the youngest and eldest horses 571 
unlikely to be competing or ridden regularly.  572 
 573 
The use of horses influenced reported influenza vaccination rates, with the highest 574 
rates found in horses used in affiliated competitions. However, some horses 575 
competing in affiliated competitions were reported as not vaccinated against equine 576 
influenza, despite the mandatory vaccination specifications. This sub-optimal equine 577 
influenza vaccination rate may illustrate the necessity for stricter enforcement of 578 
regulations at affiliated competitions; stricter monitoring has been introduced by 579 
many regulatory authorities and shows since the 2019 influenza outbreak (Horse of 580 





horse’s paper passport, which legally, must accompany the horse at all times. There 582 
is no legal requirement for leisure horse owners in the UK to vaccinate their horses, 583 
unless competing in affiliated events. No central equine influenza vaccination 584 
electronic database exists, unlike selected equine sports in some countries (e.g. 585 
Finnish Trotting and Breeding Association; (Koskinen, 2014b; Koskinen, 2014a)). 586 
Instead officials at events involving athletic horses are responsible for checking 587 
vaccination status on the horse’s arrival at the event. At each Thoroughbred race 588 
course or international competition, official Veterinary Officers employed by the 589 
British Horseracing Authority or FEI inspect passports prior to each horse entering 590 
the stables. Inspection by officials at affiliated national competitions (e.g. British 591 
Show Jumping, British Dressage etc) has been formalised since the 2019 influenza 592 
outbreak but is often reliant on amateur volunteers, with a veterinary surgeon on-call 593 
for advice. However, this study aimed to target the large numbers of leisure horse 594 
owners, who have freedom of choice around influenza vaccination, who do not 595 
compete and are therefore not required to vaccinate their horses. Although the 596 
reported vaccination rate was high (~80%), there were clearly sub-groups of horses 597 
owned by some groups of horse owners where the rate of vaccination was 598 
substantially lower. Therefore further education of horse owners about the benefits of 599 
influenza vaccination in the prevention of infection and thus improving the welfare of 600 
their horse, which was noted as an important influential factor in decision making, 601 
may be useful in altering behaviour.  602 
 603 
Only 30% of horses that never left their home premises were reported as vaccinated 604 
against equine influenza. The frequency with which horses leave their home 605 





breeding or companionship rather than competing in affiliated competition were 607 
reported as less likely to be vaccinated against equine influenza. Koskinen (2014a) 608 
and McGowan et al. (2010) also found breeding, retired and companion horses were 609 
less likely to be vaccinated against equine influenza. Lack of exposure to new horses 610 
has previously been documented as a common reason for non-vaccination (Ireland 611 
et al., 2013; Koskinen, 2014a). In the current study, “minimal exposure to new 612 
horses” was stated frequently in the free text as a reason for not vaccinating against 613 
equine influenza. Participants who did not vaccinate strongly agreed with the 614 
statement regarding non-vaccination because of lack of affiliated competition 615 
requirements. Therefore further education of horse owners about the highly 616 
contagious nature of equine influenza and the 1-2km distance over which virus can 617 
be transmitted as a wind-borne aerosol (Guthrie et al., 1999; Davis et al., 2009; 618 
Cullinane et al., 2010) may be required. 619 
 620 
When horse owners were asked about factors that influenced their decision to 621 
vaccinate against equine influenza, the welfare of their horses was the most 622 
important.  The main reason behind owners not vaccinating their horse against 623 
equine influenza was their non-participation in affiliated competitions and ownership 624 
of a horse that suffered an adverse reaction, which may be related to owners’ 625 
increased age and life experience. Adverse events have been identified as a barrier 626 
to vaccination in dogs and cats (Belshaw et al., 2018). In the UK, adverse reactions 627 
should be reported to the Veterinary Medicines Directorate who collate and 628 
disseminate information to vaccine manufacturers. Here, an adverse event was not 629 
defined but includes a failure to protect against challenge infection (more accurately 630 





including very rarely, anaphylaxis. The latter is more likely to concern individual 632 
horse owners. If adverse events are a barrier to the uptake of influenza vaccination 633 
by a sub-group of horse owners, more publicly available data is required to describe, 634 
for example, their form, frequency, any association with the inoculation site or 635 
administration method or predisposition by horse breed or age. Minor reactions 636 
(clinical signs) involving mild and transient heat and pain (tenderness) at the injection 637 
site are likely to be detected by horse owners and perhaps classified as “adverse”, 638 
without realising that such inflammation is a necessary pre-requisite for the 639 
stimulation of an effective adaptive immune response. A marked adverse reaction 640 
involving more severe inflammation may result in horses developing a very stiff neck, 641 
with severely restricted movement, which requires adaptions to enable them to eat 642 
and drink normally. In these instances, it may be that repeated administration of 643 
vaccines which contain non-viral components such as tissue culture derived proteins 644 
e.g. egg proteins and stabilizers e.g. bovine serum albumin can lead to the 645 
development of IgE mediated, hypersensitivity Type I reactions in animals with a 646 
genetic predisposition for this response (Gershwin et al., 2012). Thus although 647 
difficult, further research and then education of horse owners about the range of 648 
adverse influenza vaccine reactions may provide data to re-assure and encourage 649 
vaccine uptake. 650 
 651 
Additional potential future research around the motivation, barriers and decision-652 
making processes undertaken by horse owners with regard to uptake of vaccination 653 
may provide further insight into this complex process. In parents, vaccine hesitancy 654 
of their children is well recognised and has been defined by the World Health 655 





confidence (do not trust a vaccine or a provider), complacency (do not perceive a 657 
need for a vaccine or do not value the vaccine) and convenience (access)” (Edwards 658 
and Hackell, 2016), Multiple factors influence parents when making decisions about 659 
vaccination of their children (Rhodes, 2017; Smith et al., 2017), with concern about 660 
cost, adverse effects, attitudes to vaccination, trust and information availability 661 
featuring consistently. In pet owners (dogs, cats and rabbits), there has been a 662 
sustained reduction since 2016 in the proportion who report a primary vaccination of 663 
young animals or booster vaccination of adults, with the most common reasons for 664 
not vaccinating cited as “too expensive”, “lack of contact with other animals” and 665 
“unnecessary” (PDSA, 2019). The owner’s age, education level and gross household 666 
income were all influential factors. In dog-owners, vaccination of their pets against 667 
rabies virus in Texas, USA increased following a change from annual to triennial 668 
vaccination (Rogers, 2011), indicating the influence of vaccine intervals in owner 669 
compliance. However, reducing the frequency of equine influenza vaccinations is 670 
unlikely because protective immunity is relatively short-lived (~ 6 months) and the 671 
concurrent circulation of multiple influenza strains of different sub-lineages means 672 
that cross-protective immunity induced by an annual vaccination interval is 673 
insufficient to prevent clinical signs of disease. During the widespread 2019 influenza 674 
outbreak in western Europe, vaccine breakdown was detected in 31-34% of horses 675 
which had been vaccinated annually but succumbed to infection, (Gildea et al., 2018; 676 
Fougerolle et al., 2019) implying that the level and / or duration of protective 677 
immunity stimulated by the current vaccination protocols was insufficient to provide 678 
clinical protection against infection with heterologous strains. The reasons and risk 679 
factors underlying vaccine breakdown therefore requires additional research and in 680 





2018) and sexual dimorphism in susceptibility to infection (Barquero et al., 2007; 682 
Ryan et al., 2015). Furthermore an estimated 10% of the equine population respond 683 
poorly to influenza vaccination, by consistently generating antibody levels below the 684 
thresholds required for clinical and virological protection (Daly et al., 2004; Baguelin 685 
et al., 2010; Gildea et al., 2011; Gildea et al., 2013); the underlying causes may 686 
include genetic background, poor administration interval compliance or vaccine 687 
degradation. Regardless of the underlying reasons, these animals are likely to act as 688 
index cases during an outbreak. In Australia, vaccination uptake against Hendra 689 
virus, which can be fatal for horses and people was 11-17%. Reasons cited for the 690 
poor initial uptake included vaccine safety, cost and effectiveness (Manyweathers et 691 
al., 2017b). Improved vaccination uptake was triggered by a nearby infection 692 
outbreak (Manyweathers et al., 2017a) and vets played an important advisory role, 693 
which concurs with data from owners involving dog and cat vaccination (Belshaw et 694 
al., 2018). Increased odds ratios for non-vaccination against Hendra virus included 695 
non-vaccination against strangles, handling more than 3 horses each week, 696 
concerns over the motivation of veterinary surgeons to make money, the side effects 697 
and lack of efficacy of vaccines and non-vaccination of other pets (Goyen et al., 698 
2017); these insights may inform future research on risk factors associated with poor 699 
compliance around influenza vaccination. Thus many studies show that the factors 700 
which influence vaccination uptake in animals and people are complex and may be 701 
inter-related. Hence future studies to identify motivation and barriers to influenza 702 
vaccination of horses may prove beneficial in altering behaviour and improving 703 
vaccine uptake by horse-owners and thus limit or prevent disease caused by 704 






5. Conclusions 707 
In conclusion, this study documented a high rate of equine influenza vaccination as 708 
reported by owners in a substantial number of horses in the UK. However time since 709 
last vaccination or product administered and therefore the potential level of 710 
protection against influenza infection was unknown. Nevertheless, it identified sub-711 
populations of horses which were less likely to be vaccinated and provided novel 712 
insights into the factors that influence owners’ decisions around vaccination of their 713 
horses against equine influenza. Although these factors may alter subtly in response 714 
to the 2019 influenza outbreak in Europe, this information may nonetheless help 715 
veterinary surgeons identify “at-risk” patients and thus communicate more 716 
personalised advice to their horse-owning clients. It may also influence educational 717 
campaigns about equine influenza (e.g. the distance influenza can travel) directed to 718 
horse owners, which aim to improve uptake of vaccination against this highly 719 
infectious pathogen.   720 
  721 
Acknowledgements 722 
Ethics approval and consent to participate. This study was approved by the School 723 
of Veterinary Medicine and Science’s Research and Ethics committee (University of 724 
Nottingham) and participants gave informed consent.  725 
Consent for publication: All authors have consented to the publication of these data. 726 
Availability of data and material: All data generated or analysed during this study are 727 
included in this published article and its supplementary information files. 728 
Competing interests: The authors declare no competing interests. 729 
Funding: The study was funded by the School of Veterinary Medicine and Science. 730 





The Land Rover Burghley Horse Trials for their kind prize donations. None of these 732 
organisations had any influence on the study design or analysis and interpretation of 733 
the data.  734 
 Authors’ contributions: JHK was responsible for the initial concept, questionnaire 735 
design, project supervision, manuscript preparation and had oversight of the whole 736 
project. WB designed and analysed the survey and prepared figures. JMD 737 
contributed to survey design and writing of the manuscript. NRK, MB and DSG 738 
advised on study design and DSG and WB undertook statistical analysis.  739 
Acknowledgements: The authors would like to thank the participants who completed 740 
the survey and the University of Nottingham Press Office, the BBC, The Pony Club 741 
and The British Riding Clubs’ Association who also assisted with the survey’s 742 
publicity and distribution. 743 





Figure legends 745 
Figure 1. Impact of horse-owner related factors on horse-owners’ decision whether 746 
to vaccinate their horse against equine influenza virus. a) geographical region; b) 747 
owner’s age; c) owner’s salary; d) number of horses owned. No. of horses owned; n 748 
= 10,501. OR Odds Ratio with lower and upper 95% Confidence Intervals. Reference 749 
category is indicated by an OR of 1. Black dots: categories which are significantly 750 
different (p<0.05) from the reference category. Grey dots: categories are not 751 
significantly different. Percent of horses reported by horse owners as vaccinated: a) 752 
East Midlands 85%, South East 85%, Wales 63%, South West 73%, West Midlands 753 
73%, Scotland 74%; b) 18-25 years 83%, 26-40 years 79%, 41-60 years 78%, >60 754 
years 70%; c) £15,000-£34,999 78%, >£95,000 86%, £55,000-£74,999 83%, 755 
<£15,000 69%; d) 1 horse 88%, 2 horses 81%, 3 horses 79%, 4 horses 76%, 5 756 
horses 73%, >5 horses 66%. 757 
 758 
Figure 2. Impact of horse-related factors on horse-owners’ decision whether to 759 
vaccinate their horse against equine influenza virus. a) Horses’ age (years), n = 760 
10,483, b) Horses’ use, n=12,473; c) Frequency of horse leaving yard, n = 4,836. OR 761 
Odds Ratio with lower and upper 95% Confidence Intervals. Reference value is 762 
indicated by an OR of one. Black dots: categories which are significantly different 763 
(p<0.05) from the reference category. Grey dots: categories are not significantly 764 
different. Percent of horses reported by horse owners as vaccinated with age: a) 5-9 765 
years 83%, 25->36 years 55%, 20-24 years 69%, 0-4 years 72%; b) hacking 79%, 766 
affiliated competitions 88%, unaffiliated competitions 86%, breeding 64%, 767 





a year 54%, 2-3 times a month 82%, daily 83%, 2-6 times a week 80%, once a week 769 
79%. 770 
 771 
Figure 3. Reasons underlying horse owners’ decisions: a) to vaccinate n=3624. b) 772 
not to vaccinate against equine influenza virus. n=1215. x axis legend shows topic of 773 
each question; see Supplementary material for full text of questions.  774 
 775 
Figure 4. Previous experiences of horse-owners which influenced their decisions 776 
around equine influenza vaccination. a) influenza outbreak; b) adverse reaction 777 
following influenza vaccination. n = 4,837. Odds ratio (OR) with lower and upper 95% 778 
Confidence Intervals. Reference value is indicated by an OR of 1. Black dots: 779 
categories which are significantly different (p<0.05) from the reference category. 780 
Grey dots: categories are not significantly different. Percent of owners with previous 781 
experience of: a) an outbreak with, non-vaccinated horses 8%, vaccinated horses 782 
4%; b) an adverse reaction with, non-vaccinated horses 28%, vaccinated horses 783 
16%. 784 





Table 1. Demographics of horse owners who participated in the survey. Total number of respondents =4837. United Kingdom 
regional abbreviations: East Midlands, East of England, Greater London, North East, North West, Northern Ireland, Scotland, South 
East, South West, Wales, West Midlands, Yorkshire and the Humber.  
 Demographic  Category  
  Percent 
   (number)  
   
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
 Gender Female Male 
 Percent 98.5  1.5       
 (No.) (4765) (72) 
 
 Age (years) 18-25 26-40 41-60 >60      
 Percent 21.0 31.2 42.6 5.2 
 (No.) (1017) (1509) (2061) (250)     
    
 
 Annual income (£1000s) <15 15-34.9 35-54.9 55-74.9 75-94.9 >95 I’d rather not say  
 Percent 12.2 30.4 21.1 10.5 5.3 5.1 15.4 
 (No.) (590) (1469) (1021) (508) (256) (249) (744) 
  
 No. of horses owned 1 2 3 4 5 >5 
 Percent 40.4 28.6 14.4 6.9 3.7 6.0 
 (No.) (1955) (1381) (696) (336) (178) (291) 
 
 Region  E Mid  E Eng G Lond NE NW N Ireland Scotland SE SW Wales W Mid Y & H 
 Percent 9.9 14.0 0.8 3.9 6.8 2.3 8.3 19.1 13.8 4.3 7.7 9.1 
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